HCC risk reduction with oral nucleos(t)ide analogues in patients with chronic hepatitis B: Not perfect, not good enough-MedSci.cn

HCC risk reduction with oral nucleos(t)ide analogues in patients with chronic hepatitis B: Not perfect, not good enough

Yip, TCF; Wong, GLH

Yip, TCF (corresponding author), Chinese Univ Hong Kong, Fac Med, Dept Med & Therapeut, Hong Kong, Peoples R China.; Yip, TCF (corresponding author), Chinese Univ Hong Kong, Fac Med, Med Data Analyt Ctr, Hong Kong, Peoples R China.; Yip, TCF (corresponding author), Chinese Univ Hong Kong, Fac Med, Inst Digest Dis, Hong Kong, Peoples R China.

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

HCC risk reduction with oral nucleos(t)ide analogues in patients with chronic hepatitis B: Not perfect, not good enough

科室

工具

服务